RNAZ
TRANSCODE THERA (RNAZ)
NASDAQ
$3.05+$0.18 (+6.41%)
Price as of Aug 21, 2026 7:56 PM EDT
  • $3.0M
    Market Cap
  • -72.03%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
KEPOS CAPITAL LP
25.98%
275,000
-25,000 (-9.09%)
Mar 31, 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP
1.97%
20,854
+20,854 (+100.00%)
Dec 31, 2022
UBS GROUP AG
0.78%
8,295
+5,331 (+64.27%)
Mar 31, 2026
VANGUARD CAPITAL MANAGEMENT LLC
0.62%
6,545
+6,545 (+100.00%)
Mar 31, 2026
N/A
0.62%
6,545
+6,545 (+100.00%)
Mar 31, 2026
ACT CAPITAL MANAGEMENT, LLC
0.61%
6,500
0 (0.00%)
Sep 30, 2022
VANGUARD FIDUCIARY TRUST CO
0.28%
2,982
+2,982 (+100.00%)
Mar 31, 2026

Current Ownership Distribution

  • Insiders13.2M (48.50%)
  • Institutions10.2M (37.32%)
  • Mutual Funds3.9M (14.18%)
  • Other0 (0.00%)

Insider Transactions

  • 48.50% (13.2M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
No data found

No data found